Ramstad: Slim chance, but demand for weight-loss drugs may crack Big Pharma

It may be too much to hope for, but diet drug dynamics could be what finally breaks the pharmaceutical industry's pricing control in U.S.

Big pharma blockbuster obesity drug battle is headed for $100 billion

Novo Nordisk brings new contender in race for blockbuster obesity

Ramstad: Minnesota's Paid Family Medical Leave law hits first

A new class of drugs for weight loss could end obesity

Weight Loss Medications

Ramstad: For Owatonna, a stunning new high school is a bet on the

Anti-obesity drugs are closing the gap between dieting and

Kelowna Capital News July 25, 2010 by Kelowna CapitalNews - Issuu

Demand for weight-loss drugs fuels global rise in counterfeits

The Rise and Challenges of Weight Loss Medications in 2024

Ramstad: Slim chance, but demand for weight-loss drugs may crack